SCHEMBL30274113

SCHEMBL30274113

CC(C)(C)OC(=O)N1CC=C(c2ccc3c(ccn3C3CCC(=O)NC3=O)c2)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK7 P50613 1/20 0.43
▸ CDK13 Q14004 1/20 0.43
▸ CDK12 Q9NYV4 1/20 0.43
▸ DDB1 Q16531 10/20 0.43
▸ CRBN Q96SW2 10/20 0.43
▸ BRD4 O60885 1/20 0.43
▸ NAMPT P43490 1/20 0.43
▸ JAK1 P23458 1/20 0.42
▸ PDK4 Q16654 1/20 0.41
▸ GABRP O00591 1/20 0.39
▸ GABRD O14764 1/20 0.39
▸ GABRA1 P14867 1/20 0.39
▸ GABRB1 P18505 1/20 0.39
▸ GABRG2 P18507 1/20 0.39
▸ GABRB3 P28472 1/20 0.39
▸ GABRA5 P31644 1/20 0.39
▸ GABRA3 P34903 1/20 0.39
▸ GABRA2 P47869 1/20 0.39
▸ GABRB2 P47870 1/20 0.39
▸ GABRA4 P48169 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30273802 0.86 DDB1 (0.46) CDK7CDK13CDK12DDB1CRBN
SCHEMBL30888762 0.85 BRD4 (0.45) CDK7CDK13CDK12DDB1CRBN
SCHEMBL29197781 0.85 BRD4 (0.45) CDK7CDK13CDK12DDB1CRBN
SCHEMBL31160909 0.82 DDB1 (0.48) CDK7CDK13CDK12DDB1CRBN
SCHEMBL22836102 0.82 DDB1 (0.48) CDK7CDK13CDK12DDB1CRBN
SCHEMBL20046320 0.82 CRBN (0.54) DDB1CRBNBRD4NAMPTJAK1
SCHEMBL29367280 0.82 CRBN (0.54) DDB1CRBNBRD4NAMPTJAK1
SCHEMBL23541275 0.82 DDB1 (0.45) CDK7CDK13CDK12DDB1CRBN
SCHEMBL25036968 0.82 DDB1 (0.45) CDK7CDK13CDK12DDB1CRBN
SCHEMBL30273425 0.82 DDB1 (0.45) CDK7CDK13CDK12DDB1CRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250302815-A1 PROTEIN TYROSINE PHOSPHATASE TARGETING LIGANDS CALICO LIFE SCIENCES LLC 2025-10-02 — — US disclosed
WO-2023019166-A1 PROTEIN TYROSINE PHOSPHATASE TARGETING LIGANDS CALICO LIFE SCIENCES LLC (US) 2023-02-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250302815-A1 PROTEIN TYROSINE PHOSPHATASE TARGETING LIGANDS PTPN1, PTPN2, PTPN18 CDK7 2333/4885CDK13 2961/4885CDK12 1938/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback